MEDLIVE Posts Mid-Year Results with 4% Rise in Profit Attributable to Owners
Stock News
Aug 28
MEDLIVE (02192) has announced its interim results for the fiscal year 2026, with revenue reaching approximately RMB 315 million, marking a 1% year-on-year increase. Profit attributable to owners of the parent company stood at around RMB 162 million, reflecting a 4% growth compared to the same period last year.
The company's adjusted net profit reached approximately RMB 171 million, representing a 2.4% year-on-year increase. Basic earnings per share amounted to RMB 21.87 cents.
According to the announcement, the revenue growth was primarily driven by an increase in income from precision marketing and corporate solutions.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.